Utilization of the transradial approach (TRA) for percutaneous coronary interventions (PCI) continues to expand to more complex subsets of patients, owing largely to more favorable bleeding outcomes, which may translate into mortality benefits. However, considering the route of catheters via the radial approach as well as limitations on the size of catheters, TRA had not been applied widely in patients requiring multivessel PCI or PCI of bifurcation lesions requiring a 2‐stent strategy. In this symposium issue on the China Interventional Therapeutics (CIT) in Partnership with the Transcatheter Cardiovascular Therapeutics (TCT), 2 retrospective propensity‐matched analyses would help break the taboo! In the first article, Gao et al. demonstrated that TRA is not only feasible in a 2‐stent strategy for bifurcation lesions, but accompanied by less bleeding, shorter length of stay, and similar long‐term outcomes when compared to the transfemoral approach (TFA). Another article in this symposium issue compared TRA with TFA for simultaneous PCI for 3‐vessel coronary artery disease (CAD), which showed that PCI performed using TRA is associated with similar ischemic outcomes such as cardiovascular mortality and myocardial infarction, when compared with TFA, albeit with less bleeding complications. In both studies, the prevalence of heavily calcified lesions was low in both groups. Most of the lesions were in relatively larger diameter vessels (3.00mm). The reduced incidence of bleeding complications in procedures performed through the TRA has been previously demonstrated. Regarding the use of anticoagulants and their potential impact on bleeding outcomes in the first article, we notice that the starting dose of heparin (100U/kg) is somewhat higher than ACC/AHA guideline‐recommended use with (50– 70U/kg) or without (70–100U/kg) planned glycoprotein 2b3a inhibitors. Bivalirudin use was not reported, which has been shown to reduce bleeding complications. This anticoagulant strategy could have increased bleeding complications in patients undergoing procedures via TFA. Moreover, the majority of bleeding complications were minor (BARC type 2), which did not require blood transfusions. Besides demonstrating expansion of utilization of TRA to complex coronary interventions, these articles also demonstrate that some PCI practices in China are different from those used in the United States. For instance, the duration of hospital stay post‐PCI is considerably longer in China. Additionally, it appears that the majority of these procedures were performed in a staged fashion, where the PCI procedure was performed a few days after diagnostic coronary Disclosure statement: The authors report no financial relationships or conflicts of interest regarding the content herein. Address for reprints: Faisal Latif, M.D., F.S.C.A.I., Department of Medicine, Cardiovascular Section, VA Medical Center and University of Oklahoma Health Sciences Center, Oklahoma City, OK. Fax: þ1‐405‐456‐1576; e‐mail: faisal-latif@ouhsc.edu © 2014, Wiley Periodicals, Inc. DOI: 10.1111/joic.12114